Nestlé today unveiled two manufacturing facilities in Taizhou of Jiangsu Province with a total investment of 1 billion yuan (US$159 million) to strengthen its nutritional therapy and dermatology businesses in China.
The two adjacent factories, measuring a total of 133,000 square meters, make up the 33rd Nestlé facility in China, underscoring the company’s confidence in the future of the Chinese market.
The two factories share some supportive facilities and serve Nestlé Health Science, whose portfolio includes nutrition solutions, diagnostics, devices and drugs, and Galderma, which has a wide range of products treating dermatological conditions.
“Nestlé is fully committed to continuing to invest to support sustainable growth in China," said Magdi Batato, executive vice president and head of operations for Nestlé SA.
"By bringing the manufacturing capabilities of Nestlé Health Science and Nestlé Skin Health to China, we are in a stronger position to enhance Nestlé’s product offering and cater to consumer expectations for a good life," Batato said.
Rashid Qureshi, chairman and CEO of Nestlé China, said that the new factories underscore Nestlé’s commitment to nutrition, health and wellness, "which is fully in line with the government’s priority to build a healthy China."